Extrusion and 3D printing of novel lipid-polymer blends for oral drug applications

Advanced alginate/58S bioactive glass inks with enhanced printability, mechanical strength, and cytocompatibility for soft tissue engineering

Alginate-based hydrogels are promising biomaterials for extrusion-based bioprinting; however, their poor mechanical properties, printability, and shape integrity limit their utility in mimicking complex tissues and organs. In this study, a novel sodium alginate (Alg)/58S bioactive glass (BG)-based ink was developed for soft tissue engineering applications. The inks were characterised for shear-thinning, flowability, and shape integrity by printing various structures, including single filaments (0° and 90° nozzle movement), scaffolds, and rings. The ABG10 ink (10 wt% 58S BG in Alg) exhibited superior printability, achieving a printing accuracy of over 90 %, compared to a printing accuracy of 30-40 % for pure Alg. Fourier transform infrared spectroscopy revealed interactions between 58S BG and the Alg matrix, while scanning electron microscopy characterised the 58S BG morphology within the matrix. The storage modulus increased from 767 (pure Alg) to 13,604 Pa (ABG10), while compressive strength rose from 23 ± 3 to 43 ± 4 kPa (58 % enhancement). The cytocompatibility of the inks was assessed using an MTT assay (with SH-SY5Y cells), which confirmed that ABG10 ink supports cell viability. Overall, ABG10 hydrogel-based inks exhibited enhanced shear-thinning behaviour, printability, mechanical strength, and cytocompatibility, which could help to develop patient-specific soft tissues.

High-Performance Polymer Blends: Manufacturing of Polyetherimide (PEI)-Polycarbonate (PC)-Based Filaments for 3D Printing

The demand for high-performance polymers in 3D printing continues to grow due to their ability to produce intricate and complex structures. However, commercially available high-temperature 3D printing materials often exhibit limitations such as brittleness, warping, thermal sensitivity, and high costs, highlighting the need for advanced filament development. This study investigates the fabrication of polyetherimide (PEI) and polycarbonate (PC) blends via melt extrusion to enhance material properties for stable additive manufacturing. The addition of PC improved the processability of the blends, enabling successful extrusion at temperatures ranging from 290 to 310 °C. Differential scanning calorimetry (DSC) confirmed a shift in the softening temperature (T) of PEI, indicating effective blending. To further improve the properties of the PEI:PC blends, 1 wt% of a compatibilizer was incorporated, resulting in homogeneous microstructures as observed through scanning electron microscopy (SEM). The optimized PEI:PC (70:30) blend with compatibilizer (1 wt%) demonstrated a 49% higher storage modulus than neat PEI and a 40% greater storage modulus than ULTEM9085. Moreover, reduced melt viscosity facilitated consistent and stable printing, making these materials highly suitable for applications in aerospace and transportation, where performance and reliability are critical.

Application of 3D printing on the design and development of pharmaceutical oral dosage forms

3D printing technologies confer an unparalleled degree of control over the material distribution on the structures they produce, which has led them to become an extremely attractive research topic in pharmaceutical dosage form development, especially for the design of personalized treatments. With fine tuning in material selection and careful design, these technologies allow to tailor not only the amount of drug administered but the biopharmaceutical behaviour of the dosage forms as well. While fused deposition modelling (FDM) is still the most studied 3D printing technology in this area, others are gaining more relevance, which has led to many new and exciting dosage forms developed during 2022 and 2023. Considering that these technologies, in time, will join the current manufacturing methods and with the ever-increasing knowledge on this topic, our review aims to explore the advantages and limitations of 3D printing technologies employed in the design and development of pharmaceutical oral dosage forms, giving special focus to the most important aspects governing the resulting drug release profiles.

Mechanically promoted lipid-based filaments via composition tuning for extrusion-based 3D-printing

Lipid excipients are favorable materials in pharmaceutical formulations owing to their natural, biodegradable, low-toxic and solubility/permeability enhancing properties. The application of these materials with advanced manufacturing platforms, particularly filament-based 3D-printing, is attractive for personalized manufacturing of thermolabile drugs. However, the filament's weak mechanical properties limit their full potential. In this study, highly flexible filaments were extruded using PG6-C16P, a lipid-based excipient belonging to the group of polyglycerol esters of fatty acids (PGFAs), based on tuning the ratio between its major and minor composition fractions. Increasing the percentage of the minor fractions in the system was found to enhance the relevant mechanical filament properties by 50-fold, guaranteeing a flawless 3D-printability. Applying a novel liquid feeding approach further improved the mechanical filament properties at lower percentage of minor fractions, whilst circumventing the issues associated with the standard extrusion approach such as low throughput. Upon drug incorporation, the filaments retained high mechanical properties with a controlled drug release pattern. This work demonstrates PG6-C16 P as an advanced lipid-based material and a competitive printing excipient that can empower filament-based 3D-printing.

Combinational System of Lipid-Based Nanocarriers and Biodegradable Polymers for Wound Healing: An Updated Review

Skin wounds have imposed serious socioeconomic burdens on healthcare providers and patients. There are just more than 25,000 burn injury-related deaths reported each year. Conventional treatments do not often allow the re-establishment of the function of affected regions and structures, resulting in dehydration and wound infections. Many nanocarriers, such as lipid-based systems or biobased and biodegradable polymers and their associated platforms, are favorable in wound healing due to their ability to promote cell adhesion and migration, thus improving wound healing and reducing scarring. Hence, many researchers have focused on developing new wound dressings based on such compounds with desirable effects. However, when applied in wound healing, some problems occur, such as the high cost of public health, novel treatments emphasizing reduced healthcare costs, and increasing quality of treatment outcomes. The integrated hybrid systems of lipid-based nanocarriers (LNCs) and polymer-based systems can be promising as the solution for the above problems in the wound healing process. Furthermore, novel drug delivery systems showed more effective release of therapeutic agents, suitable mimicking of the physiological environment, and improvement in the function of the single system. This review highlights recent advances in lipid-based systems and the role of lipid-based carriers and biodegradable polymers in wound healing.

Filament-based 3D-printing of placebo dosage forms using brittle lipid-based excipients

In order to expand the limited portfolio of available polymer-based excipients for fabricating three-dimensional (3D) printed pharmaceutical products, Lipid-based excipients (LBEs) have yet to be thoroughly investigated. The technical obstacle of LBEs application is, however their crystalline nature that renders them very brittle and challenging for processing via 3D-printing. In this work, we evaluated the functionality of LBEs for filament-based 3D-printing of oral dosage forms. Polyglycerol partial ester of palmitic acid and polyethylene glycols monostearate were selected as LBEs, based on their chemical structure, possessing polar groups for providing hydrogen-bonding sites. A fundamental understanding of structure-function relationship was built to screen the critical material attributes relevant for both extrusion and 3D-printing processes. The thermal behavior of lipids, including the degree of their supercooling, was the critical attribute for their processing. The extrudability of materials was improved through different feeding approaches, including the common powder feeding and a devised liquid feeding setup. Liquid feeding was found to be more efficient, allowing the production of filaments with high flexibility and improved printability. Filaments with superior performance were produced using polyglycerol ester of palmitic acid. In-house designed modifications of the utilized 3D-printer were essential for a flawless processing of the filaments.